Cargando…

Economic burden of growth hormone deficiency in a US pediatric population

Mostrar otras versiones (1)

BACKGROUND: Pediatric growth hormone deficiency (GHD) is a rare disorder of short stature that is currently treated with daily injections of somatropin. In addition to short stature, GHD is associated with other comorbidities such as impaired musculoskeletal development, cardiovascular disease, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kaplowitz, Paul, Manjelievskaia, Janna, Lopez-Gonzalez, Lorena, Morrow, Cynthia D, Pitukcheewanont, Pisit, Smith, Alden
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Academy of Managed Care Pharmacy 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10394182/ https://www.ncbi.nlm.nih.gov/pubmed/33896224 http://dx.doi.org/10.18553/jmcp.2021.21030

Ejemplares similares

Economic Burden of Growth Hormone Deficiency in a US Pediatric Population
por: Kaplowitz, Paul B, et al.
Publicado: (2021)

PMON64 Economic Burden of Growth Hormone Deficiency in a US Adult Population
por: Smith, Alden, et al.
Publicado: (2022)

SAT611 Prevalence Of Comorbidities Among Treated And Untreated Adults With Suspected Growth Hormone Deficiency
por: Hoffman, Andrew R, et al.
Publicado: (2023)

Comparing the burden of illness in patients with alopecia areata vs atopic dermatitis in the US population from a payer perspective
por: Fenske, D. Christian, et al.
Publicado: (2023)

Identifying an Ectopic Parathyroid Adenoma Using 4DCT in a Pediatric Patient with Persistent Primary Hyperparathyroidism
por: Dhillon, Vaninder K., et al.
Publicado: (2013)

Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States
por: Udeze, Chuka, et al.
Publicado: (2023)

Correction to: Economic and Clinical Burden of Managing Sickle Cell Disease with Recurrent Vaso-Occlusive Crises in the United States
por: Udeze, Chuka, et al.
Publicado: (2023)

MON-493 A Unique Case of Severe Osteogenesis Imperfecta Due to a Novel Heterozygous Mutation in COL1A1 Gene with Overlapping Hypophosphatasia Phenotype
por: Bakhach, Marwan, et al.
Publicado: (2019)

SUN-LB66 Oral Risedronate Treatment in Children With Osteogenesis Imperfecta
por: Nguyen, Antoine T, et al.
Publicado: (2020)

SAT233 Clinical And Economic Burden Of Postsurgical Chronic Hypoparathyroidism: A US Medicare Retrospective Analysis
por: Noori, Wahidullah, et al.
Publicado: (2023)

MON-512 A De Novo Frameshift Mutation of FAM111B Gene Resulting in Progressive Osseous Heteroplasia in an African American Boy: First Case Report
por: Panjawatanan, Panadeekarn, et al.
Publicado: (2019)

The Economic and Humanistic Burden of Pediatric-Onset Multiple Sclerosis
por: Greene, Nupur, et al.
Publicado: (2022)

Understanding burden of illness for child growth hormone deficiency
por: Brod, Meryl, et al.
Publicado: (2017)

X-linked Hypophosphatemic Rickets, del(2)(q37.1;q37.3) Deletion Syndrome and Mosaic Turner Syndrome, mos 45,X/46,X, del(2)(q37.1;q37.3) in a 3-year-old Female
por: Vidmar, Alaina P., et al.
Publicado: (2017)

Assessing the Association of Formulary Copayment Changes with Real-World Treatment Patterns in Patients with Rheumatoid Arthritis on Etanercept
por: Bonafede, Machaon, et al.
Publicado: (2020)

Gender Bias in U.S. Pediatric Growth Hormone Treatment
por: Grimberg, Adda, et al.
Publicado: (2015)

Understanding Treatment Burden for Children Treated for Growth Hormone Deficiency
por: Brod, Meryl, et al.
Publicado: (2017)

Psychometric Validation of the Growth Hormone Deficiency–Child Treatment Burden Measure (GHD-CTB) and the Growth Hormone Deficiency–Parent Treatment Burden Measure (GHD-PTB)
por: Brod, Meryl, et al.
Publicado: (2022)

Treatment Patterns for Calcitonin Gene-Related Peptide Monoclonal Antibodies Including Galcanezumab versus Conventional Preventive Treatments for Migraine: A Retrospective US Claims Study
por: Varnado, Oralee J, et al.
Publicado: (2022)

Current and projected future economic burden of Parkinson’s disease in the U.S.
por: Yang, Wenya, et al.
Publicado: (2020)

Economic Burden of Osteoporosis-Related Fractures in the US Medicare Population
por: Williams, Setareh A., et al.
Publicado: (2020)

Treatment of Pediatric Growth Hormone Deficiency With Oral Secretagogues Revisited
por: Yau, Mabel, et al.
Publicado: (2021)

Growth hormone deficiency and the transition from pediatric to adult care
por: Tavares, Ana Beatriz Winter, et al.
Publicado: (2021)

Estimating the burden and economic impact of pediatric genetic disease
por: Gonzaludo, Nina, et al.
Publicado: (2018)

The effects of recombinant human growth hormone therapy on thyroid function in pediatric patients with growth hormone deficiency
por: Yao, Qian, et al.
Publicado: (2021)

OR10-06 Somatrogon Growth Hormone in the Treatment of Pediatric Growth Hormone Deficiency: Results of the Pivotal Pediatric Phase 3 Clinical Trial
por: Deal, Cheri L, et al.
Publicado: (2020)

The economic burden of pulmonary arterial hypertension (PAH) in the US on payers and patients
por: Sikirica, Mirko, et al.
Publicado: (2014)

Incremental increases in economic burden parallels cardiometabolic risk factors in the US
por: McQueen, R Brett, et al.
Publicado: (2016)

Economic Burden of Postoperative Neurocognitive Disorders Among US Medicare Patients
por: Boone, M. Dustin, et al.
Publicado: (2020)

Economic burden of hemophilia B in the US: a systematic literature review
por: Li, Nanxin (Nick), et al.
Publicado: (2019)

Drug-resistant TB: deadly, costly and in need of a vaccine
por: Manjelievskaia, Janna, et al.
Publicado: (2016)

Racial/Ethnic Disparities in the Investigation and Treatment of Pediatric Growth Hormone Deficiency
por: Hawkes, Colin Patrick, et al.
Publicado: (2021)

Economic burden, financial stress, and cost-related coping among people with uncontrolled diabetes in the U.S
por: Patel, Minal R., et al.
Publicado: (2023)

SUN-248 Growth Hormone Deficiency (GHD): Assessing Burden of Treatment in Children and Adolescents
por: Brod, Meryl, et al.
Publicado: (2019)

ODP392 Persistence with daily growth hormone treatment among pediatric patients with growth hormone deficiency in the UK
por: Loftus, Jane, et al.
Publicado: (2022)

Economic Burden of Pediatric Asthma: Annual Cost of Disease in Iran
por: SHARIFI, Laleh, et al.
Publicado: (2018)

Correction: Estimating the burden and economic impact of pediatric genetic disease
por: Gonzaludo, Nina, et al.
Publicado: (2019)

Economic burden of pediatric prescription opioid poisonings in the United States
por: Patel, Anisha M, et al.
Publicado: (2021)

Growth hormone deficiency and cerebral palsy
por: Devesa, Jesús, et al.
Publicado: (2010)

Clinical And Economic Burden Of Eosinophilic COPD In A Large Retrospective US Cohort
por: Trudo, Frank, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_o2tu2et31s0o2e7b6in2c3vlh2